| The enigmatic processing and secretion of interleukin-33. | |
| | |
MedLine Citation:
|
PMID: 20305685 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Interleukin-33 (IL-33) is the most attractive novel cytokine identified as an IL-1 family member. IL-33 was first named NF-HEV (nuclear factor from high endothelial venules), as it was known to interact with nuclear chromatin although its exact intracellular functions are still to be clarified. IL-33 is now recognized as the specific ligand for the orphan IL-1 receptor family member ST2 and to be involved in polarization of T cells towards T helper 2 cell phenotype and in activation of mast cells, bosophils, eosinophils and natural killer cells. It is essential for IL-33 to be extracellularly released in order to bind to the ST2 receptor and consequently play a crucial role in inflammatory, infectious and autoimmune diseases. However, like the IL-1 family members, IL-1beta and IL-18, IL-33 mRNA is translated without a signal sequence for secretion. Additionally, IL-33 cannot be released by the processing and secretion mechanism shared by IL-1beta and IL-18 as IL-33 is not a substrate of caspase-1 and does not require proteolysis for activation. In contrast, IL-33 can be inactivated by apoptotic caspases. Accordingly, IL-33 is proposed to be released as an alarmin from necrotic cells but to be deleted during apoptosis. Besides the known autocrine, paracrine, intracrine, juxtacrine and retrocrine mechanisms of cellular interaction with cytokines, release by necrotic cells is another pathway for a cytokine to display its function, which we suggest might be called 'necrocrine'. This mini review summarizes recent progress of how IL-33 displays potential immunoregulatory roles with a particular focus on its enigmatic production. |
| | |
Authors:
|
Weihua Zhao; Zhiqing Hu |
Related Documents
:
|
9818745 - Modulation of the pro- and anti-inflammatory cytokine balance by amphotericin b. 11340345 - Shiga toxin-1 regulation of cytokine production by human glomerular epithelial cells. 18364005 - Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? 1748475 - Il-1, il-2 and ifn-gamma production by theiler's virus-induced encephalomyelitic sjl/j ... 10679085 - Specific inhibition of glucocorticoid-induced thymocyte apoptosis by substance p. 15032645 - The possibilities and pitfalls for anti-complement therapies in inflammatory diseases. |
Publication Detail:
|
Type: Journal Article; Review Date: 2010-03-22 |
Journal Detail:
|
Title: Cellular & molecular immunology Volume: 7 ISSN: 2042-0226 ISO Abbreviation: Cell. Mol. Immunol. Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-07-05 Completed Date: 2010-09-29 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101242872 Medline TA: Cell Mol Immunol Country: China |
Other Details:
|
Languages: eng Pagination: 260-2 Citation Subset: IM |
Affiliation:
|
Department of Microbiology and Immunology, Showa University School of Medicine, Tokyo, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Humans Interleukins / immunology, metabolism*, secretion* Protein Processing, Post-Translational* |
| Chemical | |
Reg. No./Substance:
|
0/IL33 protein, human; 0/Interleukins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts.
Next Document: Th17 cells and their associated cytokines in liver diseases.